拉法醫 (6848) 月營收分析比較圖

拉法醫 (6848) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2025/10	21,281	12,238	-3.2%	73.9%	184,091	177,012	4%
2025/09	21,974	17,765	26%	23.7%	162,810	164,774	-1.2%
2025/08	17,441	19,948	10.8%	-12.6%	140,836	147,009	-4.2%
2025/07	15,741	15,973	-24.1%	-1.5%	123,395	127,061	-2.9%
2025/06	20,736	25,648	25%	-19.1%	107,654	111,088	-3.1%
2025/05	16,594	20,061	-1.1%	-17.3%	86,918	85,440	1.7%
2025/04	16,781	12,437	16.1%	34.9%	70,324	65,379	7.6%
2025/03	14,456	18,513	-21.5%	-21.9%	53,543	52,942	1.1%
2025/02	18,413	16,012	-10.9%	15%	39,087	34,429	13.5%
2025/01	20,674	18,417	40.3%	12.3%	20,674	18,417	12.3%
2024/12	14,733	12,470	9.1%	18.1%	205,245	172,467	19%
2024/11	13,500	15,722	10.3%	-14.1%	190,512	159,997	19.1%
2024/10	12,238	20,416	-31.1%	-40%	177,012	144,275	22.7%
2024/09	17,765	9,360	-10.9%	89.8%	164,774	123,859	33%
2024/08	19,948	14,357	24.9%	38.9%	147,009	114,499	28.4%
2024/07	15,973	11,202	-37.7%	42.6%	127,061	100,142	26.9%
2024/06	25,648	11,721	27.9%	118.8%	111,088	88,940	24.9%
2024/05	20,061	15,395	61.3%	30.3%	85,440	77,219	10.6%
2024/04	12,437	12,404	-32.8%	0.3%	65,379	61,824	5.8%
2024/03	18,513	12,989	15.6%	42.5%	52,942	49,420	7.1%
2024/02	16,012	22,008	-13.1%	-27.2%	34,429	36,431	-5.5%
2024/01	18,417	14,423	47.7%	27.7%	18,417	14,423	27.7%
2023/12	12,470	13,316	-20.7%	-6.3%	172,467	173,891	-0.8%
2023/11	15,722	17,137	-23%	-8.3%	159,997	160,575	-0.3%
2023/10	20,416	9,817	118.1%	108%	144,275	143,438	0.6%
2023/09	9,360	7,754	-34.8%	20.7%	123,859	133,621	-7.3%
2023/08	14,357	9,994	28.2%	43.7%	114,499	125,867	-9%
2023/07	11,202	13,566	-4.4%	-17.4%	100,142	115,873	-13.6%
2023/06	11,721	8,165	-23.9%	43.5%	88,940	102,307	-13.1%
2023/05	15,395	7,500	24.1%	105.3%	77,219	94,142	-18%
2023/04	12,404	15,713	-4.5%	-21%	61,824	86,642	-28.6%
2023/03	12,989	22,002	-41%	-41%	49,420	70,929	-30.3%
2023/02	22,008	27,125	52.6%	-18.9%	36,431	48,927	-25.5%
2023/01	14,423	21,802	8.3%	-33.8%	14,423	21,802	-33.8%
2022/12	13,316	17,126	-22.3%	-22.2%	173,891	251,182	-30.8%
2022/11	17,137	20,918	74.6%	-18.1%	160,575	234,056	-31.4%